ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,672,238 | -7.0% | 231,988 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,024,860 | -46.1% | 231,988 | -30.1% | 0.00% | -50.0% |
| Q2 2022 | $9,330,436 | +113.4% | 332,044 | +250.4% | 0.00% | +100.0% |
| Q1 2022 | $4,371,765 | -3.3% | 94,750 | +76.2% | 0.00% | 0.0% |
| Q4 2021 | $4,521,000 | +26.1% | 53,783 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,584,000 | +68.8% | 53,783 | +34.8% | 0.00% | – |
| Q2 2021 | $2,123,000 | +69.2% | 39,906 | +38.0% | 0.00% | – |
| Q1 2021 | $1,255,000 | +145.6% | 28,926 | +193.8% | 0.00% | – |
| Q4 2020 | $511,000 | – | 9,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |